David D. Cox is an accomplished regulatory affairs executive with more than 25 years of leadership in the medical device industry. Currently, as Principal at Innovatrix, Inc., he helps emerging companies navigate complex regulatory landscapes, guiding them through breakthrough device designations, PMA submissions, and FDA interactions.
David’s career includes senior roles at CytoSorbents and Integra LifeSciences, where he developed innovative regulatory strategies for Class III medical devices and human tissue products. He has consistently driven success in regulatory approvals and compliance, leveraging his expertise in aligning regulatory pathways with business objectives. David’s ability to build high-performing teams and his proven track record in resolving regulatory challenges make him a key figure in the field. His advanced degrees, including a Ph.D. in Bio-Inorganic Chemistry and an MBA, further support his role as a leader in regulatory affairs.